Objective: We investigated the different life styles among the diet structures and exercise patterns of 100 patients with refractory gout and 79 healthy volunteers; of these, we selected 39 patients and 20 healthy volunteers for serum proton magnetic resonance (H-NMR) metabolic network detection. We determined the potential biomarkers of refractory gout and attempted to explore the relation between potential biomarkers and diet structures and exercise patterns.

Methods: The study employed a questionnaire survey to analyze diet structures and exercise patterns from 100 patients of refractory gout and 79 healthy volunteers. At the same time, using H-NMR metabolic technology to analyze the metabolites present in the serum samples obtained from 39 patients of refractory gout (group B) and 20 healthy subjects (group A). Employing MestReNova (Version 8.0.1) to analyze the metabolites maps, collecting the NMR results, further importing into SIMCA-P+ 14.0 software (Umetrics, Sweden) for principal component analysis (PCA), partial least squares discriminant analysis (PLS-DA), and orthogonal partial least squares discriminant analysis (OPLS-DA) statistical analysis. Combining patterns recognition and multivariate statistics, potential biomarkers were searched. Other experimental data, including creatinine and adiponectin, were counted by the SPSS21.0. The measurement data were expressed by X ± S and t test. The counting data were expressed in percent and performed by X test.

Results: Our results revealed that patients with gout tended to be obese, and there were differences in their lifestyle with exercise, sleep, and smoking, as well as in their preference for fructose drinks, alcohol, and total and structural distribution of meat, milk, eggs, and so on when compared with the healthy volunteers. Importantly, we found the adiponectin in the gout group was lower as compared to the healthy group. Further, metabolomics in combination with KEGG analysis revealed that the biosynthesis of aminoacyl tRNA, biosynthesis of valine, leucine, and isoleucine, metabolism of alanine, aspartic, and glutamate, metabolism of glycine, serine, and threonine, phenylalanine, glycolysis/gluconeogenesis, ketone body synthesis and degradation, metabolism of D-glutamine, citric acid cycle (TCA cycle), triglyceride metabolism, and others could be used as specific biomarkers of this disease.

Conclusion: Recurrent refractory gout and formation of tophus may be related to the diet structures and lifestyles between the patients and the healthy people, and their abnormal metabolic network may be related to the disorder of mitochondrial energy metabolism, which further results in abnormal metabolism of glucose, lipids, amino acids, and deposition of uric acid in joints, peripheral connective tissue, and kidney, inducing an inflammatory response.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10797800PMC
http://dx.doi.org/10.1186/s13018-024-04540-2DOI Listing

Publication Analysis

Top Keywords

refractory gout
24
potential biomarkers
16
diet structures
16
healthy volunteers
16
structures exercise
12
patients refractory
12
gout
8
biomarkers diet
8
exercise patterns
8
patterns 100
8

Similar Publications

Refractory Tophaceous Gout With Psoriatic Arthritis: A Case Report.

Cureus

November 2024

Internal Medicine, Unidade Local de Saúde de Santo António, Porto, PRT.

Although gout is a common intermittent crystalline arthropathy, tophaceous gout is a rare condition. Flares of this disease are usually treated with anti-inflammatory drugs followed by control of serum uric acid levels. We present a refractory, severe, tophaceous gout overlapping with psoriatic arthritis, presenting with a hyper-inflamed phenotype resistant to conventional anti-inflammatory and hypouricemic agents.

View Article and Find Full Text PDF

An update on the pharmacotherapy of gout.

Expert Opin Pharmacother

January 2025

Department of Rheumatology, Royal Free London NHS Foundation Trust, London, UK.

Introduction: Gout is a common form of acute inflammatory arthritis caused by the deposition of monosodium urate crystals within synovium of joints. This leads to severe pain, reducing quality of life for patients with this condition.

Areas Covered: This review summarizes the treatment of both acute flares of gout and urate-lowering therapy based on guidance from various major international societies.

View Article and Find Full Text PDF
Article Synopsis
  • Gout is a painful form of arthritis that can lead to more severe health issues when not properly treated; Pegloticase is a drug used to treat patients who do not respond to standard gout treatments.
  • A study analyzed data from over 400 patients with chronic uncontrolled gout and found that their condition worsened significantly in the two years leading up to starting pegloticase therapy, with increases in gout-related symptoms and healthcare usage.
  • The findings suggest that identifying and treating patients sooner could help reduce the complications and healthcare needs associated with uncontrolled gout.
View Article and Find Full Text PDF
Article Synopsis
  • Amyloid goiter is a rare thyroid condition linked to AL or AA amyloidosis and sometimes associated with lipomatosis or papillary thyroid carcinoma.
  • A case of a 54-year-old male with chronic gout showed a thyroid ultrasound revealing a significant nodule, leading to a total thyroidectomy that discovered amyloid deposition and microcarcinomas.
  • The report emphasizes the need for careful assessment in patients with thyroid enlargement, particularly those with inflammation, and highlights the necessity for more research on the connections between inflammation, amyloid, and thyroid cancer.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!